Neurogene Inc. 8-K

What Happened

• Neurogene Inc. (NGNE) filed a Form 8-K on May 12, 2026 announcing it issued a press release with financial results for the quarter ended March 31, 2026. The press release is furnished as Exhibit 99.1 to the filing.
• The company also posted an updated corporate presentation on its website, furnished as Exhibit 99.2 to the 8-K. The report was signed by Christine Mikail, President and Chief Financial Officer.

Key Details

• Filing date: May 12, 2026. Quarter reported: ended March 31, 2026 (Q1 2026).
• Press release with the quarter’s results attached as Exhibit 99.1.
• Updated corporate presentation posted and furnished as Exhibit 99.2 (May 2026).
• Report signed by Christine Mikail (President, CFO).

Why It Matters

• The press release and updated presentation are the primary sources for the company’s latest earnings, revenue, cash position and any guidance — information investors use to evaluate performance and outlook.
• Retail investors should review Exhibit 99.1 and 99.2 (available on the SEC EDGAR site or Neurogene’s investor relations page) to see the actual financial figures and any commentary on operations or guidance before making investment decisions.